Growing client base Thrivable operates in the cardiometabolic patient intelligence space with rapid growth since 2019, a 10-25M revenue band, and recent leadership expansion signaling scale potential for healthcare organizations seeking patient insights and brand performance improvements.

Strategic partnerships Established collaborations with Pandata for ML initiatives and a history of diabetes-focused patient insights partnerships suggest opportunities to upsell advanced analytics, model development, and broader patient behavior research services to life sciences and healthcare brands.

Leadership signaling New VP of Business Development appointment and a recognized Best Places to Work award indicate an emphasis on enterprise sales capability and talent attraction, which can be leveraged to pursue larger pharma and health systems contracts.

Product-market fit Featuring Thrivable 365 for the GLP-1 market and a 140,000+ verified patient panel highlights a differentiated data asset, enabling targeted selling to GLP-1/molecule-specific campaigns, obesity, and diabetes programs.

Funding and momentum Recent $6M financing round and ongoing platform development align with a compelling narrative for customers seeking scalable, software-based patient insights when optimizing patient experience, brand performance, and payer-facing evidence.